We have immunohistochemically investigated P-cadherin (P-CD) expression in a series of 210 infiltrating ductal carcinomas (IDC) in an attempt to assess the biological and prognostic relevance of P-CD in patients harboring IDCs. Although only 74/210 (35%) of IDCs expressed P-CD in >5% of tumor cells (P-CD-positive carcinomas), categorical analyses revealed that P-CD-positive IDCs were larger (26 ؎ 21 cm versus 22 ؎ 11 cm, P ؍ .0568), of higher histological grade (P ؍ .0001), and had more lymph node metastases (P ؍ .0327) than P-CDnegative breast carcinomas. In addition, P-CD-positive tumors were negative for estrogen (P ؍ .0001) and progesterone receptors (P ؍ .0001) and showed reduced E-cadherin expression (P ؍ .0276) more frequently than P-CD-negative tumors. Univariate analysis carried out in 171 patients demonstrated that P-CD expression was also an indicator of poor prognosis ( 2 ؍ 8.292, P ؍ .004), extent of lymph node metastasis ( 2 ؍ 20.854, P ؍ .0000), histological grade ( 2 ؍ 12.908, P ؍ .0016), and negative progesterone receptors ( 2 ؍ 4.116, P ؍ .042). However, only histological grade and nodal metastases emerged as independent prognostic markers in the multivariate analysis. These results suggest that although P-CD expression may be involved in the progression of IDCs, its value as an independent prognostic factor remains to be established. KEY WORDS: Breast cancer, E-cadherin, P-cadherin, Prognosis Tumor progression.Mod Pathol 2001;14(7):650 -654